The pharmaceutical industry spent 9 percent more on direct-to-consumer ads in 2016 than in the year prior, with total spending reaching $5.6 billion, according to a Medical Marketing & Media report.
For the report, researchers analyzed Nielsen data on television, magazine, radio, newspaper, business-to-business, outdoor and cinema media spend. The analysis did not include digital spend.
Here are the 10 drugmakers that spent the most on direct-to-consumer ads in 2016, according to the report.
1. Pfizer — $1.19 billion
2. Bristol-Myers Squibb — $458 million
3. AbbVie — $433 million
4. Eli Lilly — $414 million
5. Allergan — $352 million
6. Johnson & Johnson — $291 million
7. Merck — $285 million
8. Novartis — $254 million
9. AstraZeneca — $225 million
10. Novo Nordisk — $206 million
More articles on supply chain:
4 reasons supply chain managers could one day become CEOs
Can employers lower drug spending by limiting PBM involvement in health plans? 4 thoughts
5 trends shaping today's supply chain industry